G01N 2333/45
Toxoplasma
G01N2333/45 (Toxoplasma) appears on 19 US grants and 32 published applications in this corpus.
Search patents in G01N- Granted patents
- 19
- Published applications
- 32
- Assignees
- 30
- Inventors
- 90
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 1 | 2 |
| 2004 | 0 | 1 |
| 2005 | 0 | 2 |
| 2006 | 2 | 1 |
| 2007 | 1 | 2 |
| 2008 | 2 | 1 |
| 2009 | 1 | 3 |
| 2010 | 3 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 1 |
| 2015 | 1 | 3 |
| 2016 | 2 | 0 |
| 2017 | 2 | 1 |
| 2018 | 2 | 1 |
| 2019 | 1 | 1 |
| 2020 | 0 | 1 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 2 |
| 2024 | 0 | 2 |
| 2025 | 0 | 2 |
| 2026 | 1 | 2 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Serological marker for the latent form of toxoplasmosis29 Sep 2026US 12,748,112 B2Centre Hospitalier Universitaire De Grenoble
- Antibodies to the surface of Toxoplasma gondii oocysts and methods of use thereof1 Oct 2019US 10,429,386 B2The Regents of the University of California
- In vivo induced toxoplasma gondii protein for application in diagnosis, vaccine and therapy28 Aug 2018US 10,060,922 B2Universiti Sains Malaysia
- Protein microarray for characterizing the specificity of the monoclonal immunoglobulins of MGUS or myeloma patients13 Mar 2018US 9,915,662 B2
- Synthesis of diverse glycosylphosphatidylinositol glycans from Toxoplasma gondii and their application as vaccines and diagnostics31 Oct 2017US 9,802,974 B2Max-Planck-Gesellschaft Zur FöRderung Der Wissenschaften E. V.
- Methods, systems, and arrays for tickborne pathogen and disease analysis9 Jul 2026US 2026/0194522 A1Vibrant Holdings, LLC
- Methods and Reagents for Toxoplasma Infection Diagnosis5 Mar 2026US 2026/0063633 A1
- Antigenic regions for the detection of anti-toxoplasma gondii igm antibodies29 May 2025US 2025/0171508 A1Biokit Research & Development S.L.U.
- Treatment and diagnosis of toxoplasma-associated disease27 Feb 2025US 2025/0067735 A1The Johns Hopkins University
- Virus-like particle comprising toxoplasma gondii protein and influenza virus protein, and diagnostic method using same14 Mar 2024US 2024/0085420 A1Health Park Incorporated
Most cited
By later US patents
- Detection of primary infections with pathogens6US 9,261,510 B2Roche Diagnostics Operations, Inc. · 2016
- Genetically engineered P30 antigen, improved antigen cocktail, and uses thereof3US 7,094,879 B2Abbott Laboratories · 2006
- Polynucleotide encoding eimeria tenella cGMP dependent protein kinase2US 6,555,358 B1Merck & Co., Inc. · 2003
- Cyclic GMP dependent protein kinase as a chemotherapeutic target for antiprotozoal agents1US 7,125,700 B2Merck & Co., Inc. · 2006
- Method for detection of malaria and other parasite infections1US 7,256,048 B2Beckman Coulter, Inc. · 2007